Griffithsin (GRFT), isolated from the red alga Griffithsia sp., shows very potent and broad-spectrum anti-HIV activity and recombinant forms can easily be produced [2, 3] .
Materials and methods
HIV-1 replication was measured in MT-4 cells and peripheral blood mononuclear cells (PBMCs) by MTS method and p24 Ag ELISA respectively. Synergism was calculated using CalcuSyn software (Biosoft, Cambridge, UK) based on the median effect principle [4] . Combination indices (CI) < 0.9 are synergistic, 0.9 < CI < 1.1 are additive and CI > 1.1 are antagonistic.
Results
We evaluated combinations of GRFT against HIV-1 clade B and clade C isolates with various glycosylation patterns on the viral envelope in PBMCs and MT-4 cells. In all combinations tested against clade B viruses BaL (R5) and NL4.3 (X4), GRFT showed synergistic activity with tenofovir, maraviroc, AMD3100 and enfuvirtide, based on the median effect principle with combination indices (CI) varying between 0.34 and 0.64 at the calculated EC 95 -level. Against the clade C viruses, ZAM18, DJ259 and ETH2220 (all R5), Cl-values varied between 0.70 and 0.79. The CI correlated with increased antiviral activity of each individual compound.
Conclusions
The evaluated two drug combinations increase their antiviral potency and support further clinical investigation and evaluation in preexposure prophylaxis in the context of HIV-1 clade B and clade C infections. Difference in glycosylation motifs in gp120 have little, if any, effects on the antiviral activity of GRFT.
